Novosanis has a long-standing relationship with the University of Antwerp. In 2013, Novosanis was founded as a spin-off company from the University of Antwerp.
CASUS, a urine-based solution to screen for cervical cancer Novosanis (Belgium) has been co-awarded a CASUS grant by Eurostars, a European Union (EU) program dedicated to supporting R&D...